GRANTS

435 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Essential Open Source Software for Science

Sponsor: The Chan Zuckerberg Initiative

Award: Applicants can request funding between $50,000 and $250,000 for one year.

Due Date: CZI will invite applications during three distinct cycles, with rounds beginning June 18, 2019; mid-December 2019; and mid-June 2020.

Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) (PAR-19-298)

Sponsor: National Institute on Aging, National Institute of Mental Health

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2019.

Rare As One Project

Sponsor: Chan Zuckerberg Initiative

Due Date: Letters of Interest due July 23, 2019.

Alzheimer’s and Infectious Diseases Research Grants

Sponsor: Infectious Diseases Society of America (IDSA) Foundation

Award: The IDSA Foundation is offering up to five one-time, $100,000 grants to researchers working to identify a microbial link to Alzheimer’s disease.

Due Date: The application period for the grant will open on June 10, and remain open through November 30.

Prevention Beyond the Pipeline

Sponsor: Alzheimer's Drug Discovery Foundation

Award: $50,000-$100,000 for epidemiological analyses based on scope of research. Up to $3 million for clinical trials based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Due Date: Letter of Intent, July 12, 2019, Invited Full Proposal, August 9, 2019; Letter of Intent, October 11, 2019, Invited Full Proposal, November 8, 2019.

Program to Accelerate Clinical Trials

Sponsor: Alzheimer's Drug Discovery Foundation

Award: Up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Due Date: Letter of Intent, July 12, 2019, Invited Full Proposal, August 9, 2019, Letter of Intent, October 11, 2019, Invited Full Proposal, November 8, 2019.

Current Filters

No filters selected

Filter By